Late-breaking trials of PCR Tokyo Valves 2026

This session presents late-breaking trials from PCR Tokyo Valves 2026, highlighting cutting-edge research in transcatheter valve therapies. Key studies include the AltaValve early feasibility study showing one-year outcomes with atrial fixation TMVR, a reappraisal of prosthesis-patient mismatch after TAVR from an invasive registry, real-world Asian experience with tricuspid transcatheter edge-to-edge repair, insights from the OCEAN-mitral registry on functional mitral regurgitation, and temporal trends in early outcomes after TAVI from the OCEAN-TAVI registry.